An update from Wuxi Biologics (Cayman) ( (HK:2269) ) is now available.
WuXi Biologics has announced it will hold conference calls on March 26, 2025, to present its 2024 annual financial results and business operations. The company aims to provide shareholders and potential investors with a deeper understanding of its performance and strategic direction. The presentation will be available in both Chinese and English, ensuring equal and timely access to information for all stakeholders. However, the company advises caution as the presentation may contain forward-looking statements subject to risks and uncertainties.
More about Wuxi Biologics (Cayman)
WuXi Biologics (Cayman) Inc. is a company incorporated in the Cayman Islands, operating in the biopharmaceutical industry. It is listed on the Hong Kong Stock Exchange and focuses on providing comprehensive biologics discovery, development, and manufacturing services to pharmaceutical and biotechnology companies globally.
YTD Price Performance: 71.30%
Average Trading Volume: 3,786
Technical Sentiment Signal: Sell
Current Market Cap: $13.92B
See more data about 2269 stock on TipRanks’ Stock Analysis page.